338 related articles for article (PubMed ID: 17981087)
61. Energy metabolism and drug response in myeloid leukaemic stem cells.
Bencomo-Alvarez AE; Rubio AJ; Gonzalez MA; Eiring AM
Br J Haematol; 2019 Aug; 186(4):524-537. PubMed ID: 31236939
[TBL] [Abstract][Full Text] [Related]
62. CD123 as a Therapeutic Target Against Malignant Stem Cells.
Sugita M; Guzman ML
Hematol Oncol Clin North Am; 2020 Jun; 34(3):553-564. PubMed ID: 32336419
[TBL] [Abstract][Full Text] [Related]
63. CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia.
Liu Y; Wang G; Zhang J; Chen X; Xu H; Heng G; Chen J; Zhao Y; Li J; Ni Y; Zhang Y; Shan J; Qian C
Stem Cell Res Ther; 2021 Jan; 12(1):86. PubMed ID: 33494824
[TBL] [Abstract][Full Text] [Related]
64. The leukemic stem cell.
Jordan CT
Best Pract Res Clin Haematol; 2007 Mar; 20(1):13-8. PubMed ID: 17336250
[TBL] [Abstract][Full Text] [Related]
65. Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance.
Hoang VT; Zepeda-Moreno A; Ho AD
Biotechnol J; 2012 Jun; 7(6):779-88. PubMed ID: 22588704
[TBL] [Abstract][Full Text] [Related]
66. Targeting mitochondrial respiration for the treatment of acute myeloid leukemia.
Carter JL; Hege K; Kalpage HA; Edwards H; Hüttemann M; Taub JW; Ge Y
Biochem Pharmacol; 2020 Dec; 182():114253. PubMed ID: 33011159
[TBL] [Abstract][Full Text] [Related]
67. Leukemia stem cells.
Buss EC; Ho AD
Int J Cancer; 2011 Nov; 129(10):2328-36. PubMed ID: 21796620
[TBL] [Abstract][Full Text] [Related]
68. Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity.
She M; Niu X; Chen X; Li J; Zhou M; He Y; Le Y; Guo K
Cancer Lett; 2012 May; 318(2):173-9. PubMed ID: 22198207
[TBL] [Abstract][Full Text] [Related]
69. Monoclonal antibodies to the myeloid stem cells: therapeutic implications of CMA-676, a humanized anti-CD33 antibody calicheamicin conjugate.
Bernstein ID
Leukemia; 2000 Mar; 14(3):474-5. PubMed ID: 10720144
[TBL] [Abstract][Full Text] [Related]
70. Antibody-targeted chemotherapy of acute myeloid leukemia using gemtuzumab ozogamicin (Mylotarg).
Sievers EL
Blood Cells Mol Dis; 2003; 31(1):7-10. PubMed ID: 12850477
[TBL] [Abstract][Full Text] [Related]
71. Acute myeloid leukemia stem cells.
Dick JE
Ann N Y Acad Sci; 2005 Jun; 1044():1-5. PubMed ID: 15958691
[TBL] [Abstract][Full Text] [Related]
72. The chronic myeloid leukemia stem cell: stemming the tide of persistence.
Holyoake TL; Vetrie D
Blood; 2017 Mar; 129(12):1595-1606. PubMed ID: 28159740
[TBL] [Abstract][Full Text] [Related]
73. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
[TBL] [Abstract][Full Text] [Related]
74. Biology and Clinical Relevance of Acute Myeloid Leukemia Stem Cells.
Reinisch A; Chan SM; Thomas D; Majeti R
Semin Hematol; 2015 Jul; 52(3):150-64. PubMed ID: 26111462
[TBL] [Abstract][Full Text] [Related]
75. Immunophenotypic Detection of Measurable Residual (Stem Cell) Disease Using LAIP Approach in Acute Myeloid Leukemia.
Zeijlemaker W; Kelder A; Cloos J; Schuurhuis GJ
Curr Protoc Cytom; 2019 Dec; 91(1):e66. PubMed ID: 31763792
[TBL] [Abstract][Full Text] [Related]
76. [Progress in the leukemic stem cell study and a novel therapeutic approach targeting leukemic stem cells].
Kikushige Y; Miyamoto T; Akashi K
Rinsho Ketsueki; 2017; 58(10):1838-1843. PubMed ID: 28978822
[TBL] [Abstract][Full Text] [Related]
77. A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression.
Kikushige Y; Miyamoto T; Yuda J; Jabbarzadeh-Tabrizi S; Shima T; Takayanagi S; Niiro H; Yurino A; Miyawaki K; Takenaka K; Iwasaki H; Akashi K
Cell Stem Cell; 2015 Sep; 17(3):341-52. PubMed ID: 26279267
[TBL] [Abstract][Full Text] [Related]
78. HDAC8 Inhibition Specifically Targets Inv(16) Acute Myeloid Leukemic Stem Cells by Restoring p53 Acetylation.
Qi J; Singh S; Hua WK; Cai Q; Chao SW; Li L; Liu H; Ho Y; McDonald T; Lin A; Marcucci G; Bhatia R; Huang WJ; Chang CI; Kuo YH
Cell Stem Cell; 2015 Nov; 17(5):597-610. PubMed ID: 26387755
[TBL] [Abstract][Full Text] [Related]
79. AntiCD3Fv fused to human interleukin-3 deletion variant redirected T cells against human acute myeloid leukemic stem cells.
Fan D; Li Z; Zhang X; Yang Y; Yuan X; Zhang X; Yang M; Zhang Y; Xiong D
J Hematol Oncol; 2015 Feb; 8():18. PubMed ID: 25879549
[TBL] [Abstract][Full Text] [Related]
80. Understanding of leukemic stem cells and their clinical implications.
Wang X; Huang S; Chen JL
Mol Cancer; 2017 Jan; 16(1):2. PubMed ID: 28137304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
